Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 09, 2023

BUY
$0.46 - $0.77 $3,471 - $5,811
7,547 Added 142.4%
12,847 $9,000
Q4 2022

Feb 10, 2023

BUY
$0.51 - $17.1 $2,693 - $90,322
5,282 Added 29344.44%
5,300 $4,000
Q2 2022

Aug 15, 2022

SELL
$0.54 - $1.41 $10,822 - $28,257
-20,041 Reduced 99.91%
18 $0
Q1 2022

May 12, 2022

BUY
$1.4 - $5.15 $22,919 - $84,310
16,371 Added 443.9%
20,059 $29,000
Q4 2021

Feb 14, 2022

SELL
$4.27 - $6.97 $41,081 - $67,058
-9,621 Reduced 72.29%
3,688 $19,000
Q3 2021

Nov 15, 2021

BUY
$5.31 - $8.25 $59,615 - $92,622
11,227 Added 539.24%
13,309 $78,000
Q2 2021

Aug 16, 2021

SELL
$6.81 - $9.23 $39,457 - $53,478
-5,794 Reduced 73.57%
2,082 $17,000
Q1 2021

May 17, 2021

BUY
$7.99 - $15.0 $47,109 - $88,440
5,896 Added 297.78%
7,876 $66,000
Q4 2020

Feb 16, 2021

SELL
$7.04 - $11.7 $218,247 - $362,711
-31,001 Reduced 94.0%
1,980 $15,000
Q3 2020

Nov 16, 2020

BUY
$9.98 - $18.04 $269,899 - $487,873
27,044 Added 455.52%
32,981 $352,000
Q2 2020

Aug 13, 2020

BUY
$7.49 - $15.16 $44,468 - $90,004
5,937 New
5,937 $90,000
Q4 2019

Feb 07, 2020

SELL
$14.6 - $18.13 $8,920 - $11,077
-611 Closed
0 $0
Q3 2019

Nov 05, 2019

SELL
$16.62 - $23.92 $9,772 - $14,064
-588 Reduced 49.04%
611 $11,000
Q2 2019

Aug 13, 2019

BUY
$17.79 - $22.88 $21,330 - $27,433
1,199 New
1,199 $27,000
Q1 2019

May 14, 2019

SELL
$11.76 - $22.15 $4,151 - $7,818
-353 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$10.42 - $21.94 $250 - $526
24 Added 7.29%
353 $4,000
Q3 2018

Nov 13, 2018

BUY
$20.4 - $24.6 $4,447 - $5,362
218 Added 196.4%
329 $8,000
Q2 2018

Aug 15, 2018

BUY
$19.02 - $24.95 $2,111 - $2,769
111 New
111 $2,000
Q4 2017

Feb 09, 2018

SELL
$18.0 - $30.0 $47,070 - $78,450
-2,615 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$21.1 - $25.15 $55,176 - $65,767
2,615
2,615 $58,000

Others Institutions Holding AXDX

About Accelerate Diagnostics, Inc


  • Ticker AXDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 99,059,904
  • Market Cap $115M
  • Description
  • Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious ...
More about AXDX
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.